The use of the “gene ao probe” platform which embraces molecular biology, cell biology, structural biology and medicinal chemistry to identify new therapeutic targets and develop potent inhibitors for these targets. Highly specialized researchers, belonging to SGC-UNICAMP, guarantee the efficiency in the execution of the platform.

Potential therapeutic targets are chosen by researchers from the SGC consortium in partnership with researchers from Brazilian companies focusing on oncological, inflammatory, neurodegenerative and infectious diseases.

arrow-down arrow-left arrow-right arrow-up Close Contato E-mail Facebook Google Home Instagram Linkedin local minus phone Pinterest plus Busca comparilhar telephone Twitter user view YouTube line-contact line-email line-facebook line-google line-home line-instagram line-linkedin line-local line-phone line-pinterest line-plus Busca line-share line-telephone line-twitter line-user line-youtube